Literature DB >> 2891292

Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.

V J Dzau1, G H Gibbons.   

Abstract

Recent data demonstrate that in addition to its conduit function, the blood vessel is an active synthetic and secretory organ containing several autocrine and paracrine systems that are involved with the local regulation of its own function. The endothelium plays a pivotal role in modulating the balance between thrombogenesis and thrombolysis. In addition, it secretes vasorelaxant and vasoconstrictive substances, growth factors and inflammatory mediators that exert paracrine influences on vascular myocyte function. The vascular myocyte also expresses autocrine substances which influence its own function. The autocrine systems include angiotensin, prostaglandins, platelet-derived growth factor, insulin-like growth factor and heparin. These local factors exert modulatory influences on myocyte contractility and growth. It is conceivable that genetic or acquired abnormalities of one or several of these check and balance systems can result in increased vascular tone, generalized vascular hypertrophy or hyperplasia, or a combination, and contribute to the pathogenesis of hypertension. These autocrine-paracrine systems may be important targets for antihypertensive drug development.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891292     DOI: 10.1016/0002-9149(87)90468-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview.

Authors:  C M Ferrario
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.

Authors:  T Natsume; M B Kardon; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

4.  Cardiomyocyte d-dopachrome tautomerase protects against heart failure.

Authors:  Yina Ma; Kevin N Su; Daniel Pfau; Veena S Rao; Xiaohong Wu; Xiaoyue Hu; Lin Leng; Xin Du; Marta Piecychna; Kenneth Bedi; Stuart G Campbell; Anne Eichmann; Jeffrey M Testani; Kenneth B Margulies; Richard Bucala; Lawrence H Young
Journal:  JCI Insight       Date:  2019-09-05

5.  PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.

Authors:  Yan Zhao; Swarajit K Biswas; Patrick H McNulty; Mark Kozak; John Y Jun; Lakshman Segar
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-16       Impact factor: 4.249

6.  LncRNA MALAT1 regulates smooth muscle cell phenotype switch via activation of autophagy.

Authors:  Tie-Feng Song; Li-Wen Huang; Ying Yuan; Hui-Qin Wang; Hong-Peng He; Wen-Jian Ma; Li-Hong Huo; Hao Zhou; Nan Wang; Tong-Cun Zhang
Journal:  Oncotarget       Date:  2017-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.